BCK CAPITAL MANAGEMENT LP - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 125 filers reported holding IMMUNOVANT INC in Q1 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
BCK CAPITAL MANAGEMENT LP ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2022$303,000
+42.9%
54,2930.0%0.22%
+32.9%
Q2 2022$212,000
-29.1%
54,2930.0%0.16%
-8.4%
Q1 2022$299,000
-35.4%
54,2930.0%0.18%
-42.6%
Q4 2021$463,000
-0.4%
54,293
+1.6%
0.31%
+12.2%
Q3 2021$465,000
+9.4%
53,459
+32.9%
0.28%
+30.5%
Q2 2021$425,000
-15.3%
40,237
+28.4%
0.21%
-22.8%
Q1 2021$502,00031,3270.28%
Other shareholders
IMMUNOVANT INC shareholders Q1 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 3,000,200$26,072,0005.92%
MANGROVE PARTNERS IM, LLC 1,139,900$9,906,0000.89%
Eventide Asset Management 4,950,000$43,016,0000.57%
Ghost Tree Capital, LLC 200,000$1,738,0000.51%
WITTENBERG INVESTMENT MANAGEMENT, INC. 140,500$1,221,0000.47%
FRAZIER MANAGEMENT LLC 585,759$5,090,0000.41%
MANGROVE PARTNERS IM, LLC 500,000$4,345,0000.39%
EcoR1 Capital, LLC 1,140,819$9,914,0000.34%
BCK CAPITAL MANAGEMENT LP 53,459$465,0000.28%
PLATINUM INVESTMENT MANAGEMENT LTD 555,065$4,824,0000.14%
View complete list of IMMUNOVANT INC shareholders